-
Lung Cancer Drugs Shows Promise for Treatment-Resistant Melanoma
11 Jun 2025 19:07 GMT
… and lung cancers. The researchers tested two drugs from this class, Erbitux (cetuximab) and …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … and in combination with cetuximab with or without chemotherapy … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … as in combination with cetuximab with or without chemotherapy … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, …
EGFR inhibitors — including drugs like Erbitux (cetuximab), Vectibix (panitumumab), Tarceva (erlotinib) …
-
Alkem Launches 'PRAYAS': A Bold Step Toward Accessible Cancer Care
04 Jul 2025 12:35 GMT
… , ovarian, and non-small cell lung cancer, among others. The program offers … support initiative launched alongside CETUXA (Cetuximab), reinforcing its commitment to affordability …
-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
-
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
20 Mar 2025 20:15 GMT
… NBTXR3) for patients with lung cancer (NSCLC) to be … presented at the 2025 European Lung Cancer Conference (“ELCC”). ABSTRACT … Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”)
Saumil J. … therapy, with or without cetuximab, for the treatment …
-
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer
27 Feb 2025 05:59 GMT
… cell lung cancer (NSCLC) and small cell lung cancer.1,2 … was combined with cetuximab,26 it demonstrated inhibitory … G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity … non-small cell lung cancer (NSCLC). Lung Cancer. 2019;137:113 …
-
Revisit Every OncLive On Air Episode From June 2025
01 Jul 2025 21:03 GMT
… -type advanced non–small cell lung cancer (NSCLC). He also highlighted the … they progress on FOLFOX with cetuximab [Erbitux], maybe panitumumab [Vectibix], and then …
-
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
21 Jan 2025 07:30 GMT
… 3 unresectable non-small cell lung cancer receiving standard of care chemoradiation … study in non-small cell lung cancer brings us another step closer … radiation therapy, with or without cetuximab, for the treatment of patients …
About
© 1995-2025